Correction: The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer
Cancer Res
.
2022 Aug 25:OF1.
doi: 10.1158/0008-5472.CAN-22-2377.
Online ahead of print.
Authors
Yun Jung Choi
,
Da-Som Kim
,
Young Hoon Sung
,
Dong Ha Kim
,
Kyungtaek Im
,
Hyeonjeong Lee
,
Chae Won Lee
,
Jeongin Cho
,
Joongkee Min
,
Dong-Cheol Woo
,
Sung-Eun Kim
,
Sunho Lee
,
Yun Jeong Kong
,
Hyung Chul Ryu
,
Jae-Sun Kim
,
Rajesh Rengasamy
,
Wonjun Ji
,
Chang-Min Choi
,
Jae Cheol Lee
,
Jin Kyung Rho
PMID:
36006687
DOI:
10.1158/0008-5472.CAN-22-2377
No abstract available
Publication types
Published Erratum